title: Comment on "determination of treosulfan in plasma and urine by HPLC with refractometric detection; pharmacokinetic studies in children undergoing myeloablative treatment prior to haematopoietic stem cell transplantation" by F.K. Glowka et al. [J. Chromatogr. B 850 (2007) 569-574].
authors: University of Münster, Institute of Pharmaceutical and Medicinal Chemistry, and Department of Paediatric Haematology and Oncology, Universith Children's Hospital, Münster, Germany. georg.hempel@uni-muenster.de
authors: Georg
authors: G
authors: Hempel
authors: Joachim
authors: J
authors: Boos
mesh_terms: D000293:Adolescent; D018906:Antineoplastic Agents, Alkylating / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D002066:Busulfan / Q000031:analogs & derivatives* / Q000032:analysis / Q000493:pharmacokinetics; D002648:Child; D002675:Child, Preschool; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015203:Reproducibility of Results
chemical_list: D018906:Antineoplastic Agents, Alkylating; C018404:treosulfan; D002066:Busulfan